ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686).

Chris Karlovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.